Literature DB >> 770312

Mitogenic and adjuvant activity of a methanol extraction residue (MER) of tubercle bacilli on mouse lymphoid cells in vitro.

S Ben-Efraim, T Diamantstein.   

Abstract

The mitogenic and adjuvant effect in vitro of MER (methanol extracted residue of tubercle bacilli), on Balb/C and nu/nu immunocompetent cells was examined and compared with the effect of PPD, LPS, DS, PHA and ConA. MER activated DNA synthesis in spleen cells of Balb/C and nu/nu mice and in blood cultures of Balb/C. The stimulation of DNA synthesis by MER in spleen cells was not macrophage dependent. Bone marrow and 1ymph node cells were slightly stimulated while thymus cells were not affected. Both MER and PPD enhanced the in vitro immune response of Balb/C mice to SRBC and to TNP (trinitrophenyl) hapten. MER, LPS and PPD enhanced the immune response of nude spleen cells to SRBC in vitro.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 770312     DOI: 10.3109/08820137509055794

Source DB:  PubMed          Journal:  Immunol Commun        ISSN: 0090-0877


  4 in total

1.  Nonspecific stimulation of lymphocytes by tuberculin.

Authors:  B M Sultzer; B S Nilsson; D Kirschenbaum
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

2.  Induction by an immunogenic immunomodulating agent of nonspecific T cell suppression of lymphocyte responsiveness in MLR but not of antibody production.

Authors:  C Reuben; D Halperin; S Ben-Efraim; D W Weiss
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria.

Authors:  Keiji Hirota; Keishiro Tomoda; Hiroyuki Inagawa; Chie Kohchi; Gen-Ichiro Soma; Kimiko Makino; Hiroshi Terada
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

4.  Immunological activities of purified preparations of enterobacterial common antigen.

Authors:  P J Gannon; D M Jacobs; A Marx; H Mayer; E Romanowska; E Neter
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.